CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, L.
Right arrow Articles by Horwitz, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, L.
Right arrow Articles by Horwitz, S. B.

Cell Growth & Differentiation, Vol 6, Issue 12 1505-1512, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Coordination of transcription factors, NF-Y and C/EBP beta, in the regulation of the mdr1b promoter

L Yu, Q Wu, CP Yang and SB Horwitz
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

The expression of mdr genes that encode P-glycoprotein, an integral membrane drug transporter, has been associated with the emergence of the multidrug resistance phenotype during treatment with cancer chemotherapeutic drugs. To understand the regulation of the mdr genes, the murine mdr1b promoter has been isolated and characterized in our laboratory. Three nuclear protein binding sites that interact with nuclear proteins present in both drug-sensitive and -resistant murine macrophage-like 1774.2 cells have been localized to the promoter. In this report, transcription factor NF-Y has been identified as binding to the Y-box sequence in site 1 and as a major factor in the regulation of the murine mdr1b promoter in the mouse adrenal cell line, Y-1, that endogenously expresses the mdr1b gene. The expression of CCAAT/enhancer binding protein beta (C/EBP beta) in Y-1 cells augmented mdr1b promoter activity and resulted in an increased level of mdr1b mRNA. The effect of C/EBP beta expression on mdr1b promoter activity was sensitive to mutations in the Y-box, suggesting that coordination of NF-Y with C/EBP beta is required for further activation of the mdr1b promoter. Our studies have indicated that NF-Y is a critical factor for the mdr1b promoter, and its coordination with other factors, such as C/EBP beta, could be an important mechanism involved in mdr1b gene expression.


This article has been cited by other articles:


Home page
J Biol ChemHome page
J. Yang, J. Huang, T. K. Chatterjee, E. Twait, and R. A. Fisher
A Novel Mechanism Involving Coordinated Regulation of Nuclear Levels and Acetylation of NF-YA and Bcl6 Activates RGS4 Transcription
J. Biol. Chem., September 24, 2010; 285(39): 29760 - 29769.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. K. Chen, S. Sale, T. Tan, R. P. Ermoian, and B. I. Sikic
CCAAT/Enhancer-Binding Protein {beta} (Nuclear Factor for Interleukin 6) Transactivates the Human MDR1 Gene by Interaction with an Inverted CCAAT Box in Human Cancer Cells
Mol. Pharmacol., April 1, 2004; 65(4): 906 - 916.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
M.-C. Mathieu, I. Lapierre, K. Brault, and M. Raymond
Aromatic Hydrocarbon Receptor (AhR){middle dot}AhR Nuclear Translocator- and p53-mediated Induction of the Murine Multidrug Resistance mdr1 Gene by 3-Methylcholanthrene and Benzo(a)pyrene in Hepatoma Cells
J. Biol. Chem., February 16, 2001; 276(7): 4819 - 4827.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. S. Radomska, A. B. Satterthwaite, N. Taranenko, S. Narravula, D. S. Krause, and D. G. Tenen
A Nuclear Factor Y (NFY) Site Positively Regulates the Human CD34 Stem Cell Gene
Blood, December 1, 1999; 94(11): 3772 - 3780.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C.-Y. Kao, A. Tanimoto, N. Arima, Y. Sasaguri, and R. Padmanabhan
Transactivation of the Human cdc2 Promoter by Adenovirus E1A: E1A INDUCES THE EXPRESSION AND ASSEMBLY OF A HETEROMERIC COMPLEX CONSISTING OF THE CCAAT BOX BINDING FACTOR, CBF/NF-Y, AND A 110-kDa DNA-BINDING PROTEIN
J. Biol. Chem., August 13, 1999; 274(33): 23043 - 23051.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C. Gomez, D. G. Perez, E. Lopez-Bayghen, and E. Orozco
Transcriptional Analysis of the EhPgp1 Promoter ofEntamoeba histolytica Multidrug-resistant Mutant
J. Biol. Chem., March 27, 1998; 273(13): 7277 - 7284.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Sundseth, G. Macdonald, J. Ting, and A. C. King
DNA Elements Recognizing NF-Y and Sp1 Regulate the Human Multidrug-Resistance Gene Promoter
Mol. Pharmacol., June 1, 1997; 51(6): 963 - 971.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M.-C. Mathieu, I. Lapierre, K. Brault, and M. Raymond
Aromatic Hydrocarbon Receptor (AhR){middle dot}AhR Nuclear Translocator- and p53-mediated Induction of the Murine Multidrug Resistance mdr1 Gene by 3-Methylcholanthrene and Benzo(a)pyrene in Hepatoma Cells
J. Biol. Chem., February 16, 2001; 276(7): 4819 - 4827.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.